pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 8·1 min read
save

Congo Ebola frontline health workers face low pay and exhaustion amid outbreak

Jun 8, 2026·read at STAT ↗Negative

Dr. Richard Lokudu, medical director of Mongbwalu General Referral Hospital, says he and his colleagues are receiving almost no compensation while treating patients in the current Ebola outbreak.

Workers report staying on duty for days without a break to eat, receiving alerts of suspected cases even late at night, and fearing they may become infected despite strict infection-prevention measures.

Health officials say the outbreak, caused by the rare Bundibugyo strain, emerged silently in the mining town of Mongbwalu in Ituri province. The gold-mining environment, with muddy pools, narrow pits and crowded camps, creates conditions that facilitate virus spread.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest”

read at STAT ↗
977 words · retrieved Jun 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PFIZER2Ultragenyx Pharmaceutical Inc.2ASTRAZENECALILLYNOVOROCHE
drugs
Obesity2
topics
Infectious Disease3Obesity2Rare Disease2Alzheimer's DiseaseGLP-1 receptorHematologyType 2 DiabetesVaccines

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 8STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trialsSTAT
  • 15h agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Jun 12STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and moreSTAT